Dry Eye clinical trials at UCSF

2 in progress, 1 open to eligible people

Showing trials for

  • Azithromycin for Meibomian Gland Disease

    open to eligible people ages 18 years and up

    This study aims to elucidate the effectiveness of oral azithromycin in treating symptomatic dry eye syndrome secondary to Meibomian gland dysfunction.

    San Francisco, California

  • Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)

    Sorry, accepting new patients by invitation only

    This study is designed to measure how common nerve abnormalities are within a group of patients who feel discomfort within their eyes.

    San Francisco, California and other locations

Our lead scientists for Dry Eye research studies include .

Last updated: